论文部分内容阅读
葆乐辉是近年用于临床的新型无水茶碱控释制剂，由美国仙灵葆雅药物有限公司研究，它具有速效及长效控释的特点。本文研究口服葆乐辉对慢性阻塞性肺疾病（ＣＯＰＤ）患者的平喘作用、副作用及血药浓度，以评价其临床疗效与安全性。１ 材料与方法１．１ 病例 慢性支气管炎急性发
Bao Lehui is a new anhydrous theophylline controlled release preparation for clinical use in recent years. It is researched by the United States Spirit Pharmaceutical Co., Ltd. and has the characteristics of quick-acting and long-acting controlled release. This article studies oral anti-asthma in patients with chronic obstructive pulmonary disease (COPD) patients with side effects, side effects and plasma concentrations to evaluate its clinical efficacy and safety. 1 Materials and Methods 1.1 cases of acute exacerbation of chronic bronchitis